Resmed (RSMDF) Inventory (2010 - 2026)

Resmed (RSMDF) has reported Inventory for 17 consecutive years, with $945.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory rose 1.95% year-over-year to $945.8 million; the trailing twelve-month figure through Jun 2026 stood at $945.8 million (up 1.95% YoY), and the FY2026 full-year result was $945.8 million, up 1.95% from the prior year.
• Inventory rose to $945.8 million in Q2 2026 per RSMDF's latest filing, from $911.9 million in the prior quarter.
• Across five years, Inventory topped out at $1.0 billion in Q1 2023 and bottomed at $664.9 million in Q1 2022.
• Historically, Inventory has averaged $896.2 million across 5 years, with a median of $920.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Inventory soared 70.7% in 2022, then decreased 17.98% in 2024.
• Over 5 years, Inventory stood at $989.0 million in 2022, then declined by 5.64% to $933.2 million in 2023, then declined by 5.48% to $882.1 million in 2024, then grew by 4.53% to $922.0 million in 2025, then advanced by 2.58% to $945.8 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $945.8 million, $911.9 million, and $922.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.